Pharm-Bio Serv Inc (PBSV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
(Values in U.S. thousands)
| 04-2026 | 01-2026 | 10-2025 | 07-2025 | 04-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 266 | 33 | -101 | -100 | 104 |
| Depreciation Amortization | 58 | 44 | 229 | 170 | 112 |
| Accounts receivable | -355 | -277 | 204 | N/A | -124 |
| Other Working Capital | -1,007 | -386 | -341 | -961 | -867 |
| Other Operating Activity | 283 | 195 | -206 | 396 | 44 |
| Operating Cash Flow | $-756 | $-390 | $-215 | $-495 | $-731 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 877 | 2,762 | -1,460 | -603 | -2,234 |
| PPE Investments | 2 | 5 | -7 | -6 | -4 |
| Investing Cash Flow | $880 | $2,767 | $-1,466 | $-610 | $-2,239 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | -2 | -2 | -31 | -22 | -17 |
| Dividend Paid | -1,718 | N/A | -1,720 | -1,720 | -1,720 |
| Financing Cash Flow | $-1,720 | $-2 | $-1,751 | $-1,742 | $-1,737 |
| Exchange Rate Effect | 8 | 10 | 45 | 37 | 33 |
| Beginning Cash Position | 3,379 | 3,379 | 6,767 | 6,767 | 6,767 |
| End Cash Position | 1,792 | 5,764 | 3,379 | 3,958 | 2,093 |
| Net Cash Flow | $-1,588 | $2,384 | $-3,388 | $-2,810 | $-4,674 |
| Free Cash Flow | |||||
| Operating Cash Flow | -756 | -390 | -215 | -495 | -731 |
| Capital Expenditure | -5 | -2 | -7 | -6 | -4 |
| Free Cash Flow | -760 | -393 | -222 | -501 | -735 |